Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0037-1605389
Hyaluronic Acid Intra-Articular Injections in Patients Affected by Moderate to Severe Glenohumeral Osteoarthritis: A Prospective Randomized Study
Publication History
Publication Date:
11 August 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00033766/201703/lookinside/thumbnails/10-1055-s-0037-1605389_1705-1.jpg)
Abstract
Purpose The aim of this study was to evaluate the efficacy and safety of intra-articular injection treatment with high molecular weight HA (Hyalubrix, 30 mg/2 mL, molecular weight > 1,500 kDa) in patients affected by moderate to severe glenohumeral osteoarthritis (OA).
Methods Seventy-eight patients, affected by shoulder OA grade II–IV were randomized in two groups. Patients included in case group were treated with three intra-articular injections of HA and a specific physiotherapy program, whereas patients included in the control group received the only physical therapy. The follow-up examination was 6 months for both groups. The evaluation of functional status of treated shoulder, range of motion, and pain was performed before treatment and at the final follow-up examination by means of the Constant score. The safety evaluation of the treatment was also performed recording any adverse events.
Results Statistical analysis revealed a significant difference (p < 0.05) between the two groups in terms of pain reduction and improvement in the activities of daily living. In particular, case group subjects affected by grade III and IV OA had a significant improvement in the Constant score (18.2 ± 5.4 and 19.2 ± 5.9, respectively).
Conclusion This study showed that the combination of intra-articular injection of hyaluronic acid (Hyalubrix, 30 mg/2 mL) with physical therapy program was more effective in comparison with the only physical therapy in reducing pain in patients affected by glenohumeral OA.
Level of Evidence Level II, randomized controlled study.
-
References
- 1 Nakagawa Y, Hyakuna K, Otani S, Hashitani M, Nakamura T. Epidemiologic study of glenohumeral osteoarthritis with plain radiography. J Shoulder Elbow Surg 1999; 8 (06) 580-584
- 2 Chakravarty K, Webley M. Shoulder joint movement and its relationship to disability in the elderly. J Rheumatol 1993; 20 (08) 1359-1361
- 3 Steinfeld R, Valente RM, Stuart MJ. A commonsense approach to shoulder problems. Mayo Clin Proc 1999; 74 (08) 785-794
- 4 Memel DS, Kirwan JR, Sharp DJ, Hehir M. General practitioners miss disability and anxiety as well as depression in their patients with osteoarthritis. Br J Gen Pract 2000; 50 (457) 645-648
- 5 Andrews JR. Diagnosis and treatment of chronic painful shoulder: review of nonsurgical interventions. Arthroscopy 2005; 21 (03) 333-347
- 6 Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis?. Rheumatol Int 2006; 26 (06) 536-540
- 7 Carfagno DG, Ellenbecker TS. Osteoarthritis of the glenohumeral joint: nonsurgical treatment options. Phys Sportsmed 2002; 30 (04) 19-30
- 8 Blaine T, Moskowitz R, Udell J. , et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 2008; 90 (05) 970-979
- 9 Brander VA, Gomberawalla A, Chambers M, Bowen M, Nuber G. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. PM R 2010; 2 (04) 259-267
- 10 Itokazu M, Matsunaga T. Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 1995; 17 (05) 946-955
- 11 Ramonda R, Franceschini M, Leardini G. Treatment of shoulder periarthritis with hyaluronic acid. Riv Ital Biol Med 1998; 51 (2 Suppl): 1
- 12 American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43 (09) 1905-1915
- 13 Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105 (1B): 31S-38S
- 14 Jordan KM, Arden NK, Doherty M. , et al; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62 (12) 1145-1155
- 15 Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician 2012; 85 (01) 49-56
- 16 Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rhematol Suppl 1993; 39: 3-9
- 17 Kwon YW, Eisenberg G, Zuckerman JD. Sodium hyaluronate for the treatment of chronic shoulder pain associated with glenohumeral osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. J Shoulder Elbow Surg 2013; 22 (05) 584-594
- 18 Colen S, Haverkamp D, Mulier M, van den Bekerom MP. Hyaluronic acid for the treatment of osteoarthritis in all joints except the knee: what is the current evidence?. BioDrugs 2012; 26 (02) 101-112
- 19 Gu Q, Zhou N, Shanghai J. Research progress of viscosupplementation [Article in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2011; 25 (06) 755-760
- 20 Abate M, Pulcini D, Di Iorio A, Schiavone C. Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharm Des 2010; 16 (06) 631-640
- 21 Merolla G, Sperling JW, Paladini P, Porcellini G. Efficacy of Hylan G-F 20 versus 6-methylprednisolone acetate in painful shoulder osteoarthritis: a retrospective controlled trial. Musculoskelet Surg 2011; 95 (03) 215-224
- 22 Abatangelo G, O'Regan M. Hyaluronan: biological role and function in articular joints. Eur J Rheumatol Inflamm 1995; 15: 9-16
- 23 Altman RD, Moskowitz R. ; Hyalgan Study Group. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998; 25 (11) 2203-2212
- 24 Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995; 15: 25-31
- 25 Maheu E. Hyaluronan in knee osteoarthritis: a review of clinical trials with Hyalgan. Eur J Rheumatol Inflamm 1995; 15: 17-24
- 26 Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999; 28 (11, Suppl) 5-7
- 27 Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998; 16 (04) 441-449
- 28 Listrat V, Ayral X, Patarnello F. , et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997; 5 (03) 153-160
- 29 Migliore A, Tormenta S, Martin Martin LS. , et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 2006; 25 (03) 389-393
- 30 Stitik TP, Blacksin MF, Stiskal DM. , et al. Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil 2007; 88 (02) 135-141
- 31 Phiphobmongkol V, Sudhasaneya V. The effectiveness and safety of intra-articular injection of sodium hyaluronate (500-730 kDa) in the treatment of patients with painful knee osteoarthritis. J Med Assoc Thai 2009; 92 (10) 1287-1294
- 32 Foti C, Cisari C, Carda S. , et al. A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med 2011; 47 (03) 407-415
- 33 Vetro A, Iovane A, Di Gesu M, Giordan N, Mantia F, Mantia R. Pain relief and functional recovery over a six-month period after intra-articular injection with sodium hyaluronate (Mw 1500 - 2000 Kda) in osteoarthritis of the knee. Eur J Musculoskel Dis 2014; 3: 25-33
- 34 Porcellini G, Merolla G, Giordan N. , et al. Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial. Joints 2016; 3 (03) 116-121
- 35 Di Giacomo G, De Gasperis N. The role of hyaluronic acid in patients affected by glenohumeral osteoarthritis. J Biol Regul Homeost Agents 2015; 29 (04) 945-951
- 36 Silverstein E, Leger R, Shea KP. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med 2007; 35 (06) 979-985
- 37 Colen S, Geervliet P, Haverkamp D, Van Den Bekerom MP. Intra-articular infiltration therapy for patients with glenohumeral osteoarthritis: a systematic review of the literature. Int J Shoulder Surg 2014; 8 (04) 114-121